StockWatch
·
Pharmaceuticals
Acquisitions17 Jul 2026, 06:20 pm

Alkem Labs completes acquisition of Occlutech Holding AG

AI Summary

Alkem Laboratories Limited announced the completion of its acquisition of Occlutech Holding AG, a Swiss company. The acquisition, through its wholly owned subsidiary Alkem Medtech Private Limited, involved acquiring between 51% and 55% of Occlutech's equity share capital. Following this transaction, Occlutech will become a step-down subsidiary of Alkem Laboratories. This development is a continuation of previous intimations made by the company regarding the acquisition process.

Key Highlights

  • Alkem Medtech has successfully acquired Occlutech Holding AG.
  • Occlutech will now operate as a step-down subsidiary of Alkem Labs.
  • The acquisition involved a stake of 51% to 55% in Occlutech.
  • This completes the acquisition process initiated earlier this year.